Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Cheeky's Board!
Posted On: 10/22/2014 5:17:28 PM
Post# of 94269
Avatar
Posted By: pennybuster
***** $HEB *****

SQUIRE PATTON INKS EBOLA DRUGMAKER: Hemispherx BioPharma, Inc. has hired Squire Patton Boggs to help raise awareness and tackle regulatory issues around two potential Ebola drugs. The company believes that two of its products — the drugs Ampligen and Alferon — could possibly be effective as treatments for the virus that’s currently ravaging several West African countries. Squire Patton will work communicating the company’s message to officials in the United States and abroad. “We are pleased to establish a strategic relationship with [Squire Patton Boggs], one of the world’s finest governmental, international relations, biopharma licensing and corporate M&A law firms,” said Thomas Equels of Hemispherx in a statement. “We welcome [Squire Patton] to the Hemispherx team effort to bring our experimental drug Ampligen and FDA approved drug Alferon online as potential therapeutics for Ebola and other lethal viruses for which no effective therapy exists.” Stuart Pape, Ed Newberry, Taryn Frideres, Robert Kapla and Kevin O'Neill will all work on the account for Squire Patton.

http://www.politico.com/polit…/…/politico...15751.html

Google their names. Very, very, very impressive.

(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site